Results 71 to 80 of about 6,753 (182)

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation [v1; ref status: indexed, http://f1000r.es/2jm]

F1000Research, 2014
We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild ...
Chris G. Yedinak, Shirley McCartney, Troy H. Dillard, Kevin S. Wei, Maria Fleseriu   +4 more
doaj   +1 more source

Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial

Journal of Ovarian Research
Background This study compared the effectiveness of cabergoline and hydroxychloroquine in preventing ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCOS) undergoing controlled ovarian stimulation.
Elnaz Salari, Negar Ajabi Ardehjani, Ladan Kashani, Kasra Jafari, Ashraf Moini   +4 more
doaj   +1 more source

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study

, 2022
Robert Krysiak, Karolina Kowalcze, Bogusław Okopień   +2 more
openalex   +1 more source

Cabergoline: an effective treatment for conception in prolactinoma

, 2022
Zahra Safdar, Omair Afzal, Rabia Nafees, Nabeel Choudhary   +3 more
openalex   +1 more source

Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels—a retrospective study [PDF]

, 2013
Yu Hung Lin, Mei Zen Huang, Jiann‐Loung Hwang, Heng Ju Chen, Bih Chwen Hsieh, Lee Huang, Chii‐Ruey Tzeng, Kok Min Seow   +7 more
openalex   +1 more source

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma [PDF]

, 2022
Annabelle G Hayes, Masoumeh G. Shirazi, Anand Thiyagarajah, David J. Torpy, Sunita M C De Sousa   +4 more
openalex   +1 more source

Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline [PDF]

, 2008
Annamaria Colao, Maurizio Galderisi, Antonella Di Sarno, M. Pardo, Maria Gaccione, Marianna D’Andrea, Ermelinda Guerra, Rosario Pivonello, Giuseppe Lerro, Gaetano Lombardi   +9 more
openalex   +1 more source

Cabergoline as a Preventive Migraine Treatment: An Investigator-Initiated Randomized Controlled Trial [PDF]

, 2023
Astrid Johannesson Hjelholt, Flemming W. Bach, Helge Kasch, Henrik Støvring, Troels S. Jensen, Jens Otto Lunde Jørgensen   +5 more
openalex   +1 more source

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar

Therapeutics and Clinical Risk Management, 2016
Doua AlSaad,1 Samah ElSalem,1 Palli Valapila Abdulrouf,1 Binny Thomas,1,2 Tayseer Alsaad,3 Afif Ahmed,1 Moza AlHail4 1Department of Pharmacy, Women’s Hospital, Hamad Medical Corporation, Doha, Qatar; 2Department of Pharmacy and Life Sciences ...
AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M   +6 more
doaj  

The Effect of Cabergoline on the Clinical and Immunological Aspects of Rheumatoid Arthritis Induced in Wistar Rats

Armaghane Danesh Bimonthly Journal, 2019
Background & aim: The anti-inflammatory effects of cabergoline have been documented in various studies. The purpose of the present study was to evaluate the effects of cabergoline administration (as a potent D2 agonist) on clinical aspects and immune ...
E Shaftaloud, SM Abtahi Froushani, N Delirezh   +2 more
doaj